CurveBeam AI Limited (ASX:CVB)
0.0950
-0.0020 (-2.06%)
At close: May 14, 2025, 4:00 PM AEST
CurveBeam AI Company Description
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America.
The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions.
It is also involved in AI’s Deep Learning AI based platform aids in bone microstructure analysis. The company’s target customers include orthopedic practices, imaging centers, and hospitals.
CurveBeam AI Limited was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
CurveBeam AI Limited
Country | Australia |
Founded | 2009 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 50 |
CEO | Gregory Brown |
Contact Details
Address: 2800 Bronze Drive Hatfield, 19440 United States | |
Phone | 267-483-8081 |
Website | curvebeamai.com |
Stock Details
Ticker Symbol | CVB |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU0000289761 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Gregory Brown BSc, MBA | Chief Executive Officer, MD and Director |
Ura Phillip Stephen Auckland | Chief Financial Officer and Company Secretary |
Arun Bahadur Singh | Chief Operating Officer, Chief Technology Officer (CT), President of US and Europe Division and Executive Director |
Dr. Aloys Mbala | Co-Founder |
Ali Ghasemzadeh | Co-Founder |
S. Turner Dean | Chief Sales Officer |
Vinti Singh | Vice President of Marketing |
Dr. Yu Peng B.S., Ph.D. | Chief Technology Officer (Artificial Intelligence) |
Prof. Ego Seeman | Medical Director - Endocrinology |